<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35099775</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1568-5888</ISSN><JournalIssue CitedMedium="Print"><Volume>30</Volume><Issue>7-8</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation</Title><ISOAbbreviation>Neth Heart J</ISOAbbreviation></Journal><ArticleTitle>The presence of cardiotropic viral genomes is not increased in atrial tissue of atrial fibrillation patients.</ArticleTitle><Pagination><StartPage>377</StartPage><EndPage>382</EndPage><MedlinePgn>377-382</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12471-022-01660-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Infections with potentially cardiotropic viruses are associated with the development of atrial fibrillation (AF). However, whether direct viral infection of the atria is involved in the pathogenesis of AF is unclear. We have therefore analysed the presence of cardiotropic viral genomes in AF patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Samples of left atrial tissue were obtained from 50&#xa0;AF patients (paroxysmal, n&#x202f;=&#x2009;20; long-standing persistent/permanent, n&#x202f;=&#x2009;30) during cardiac surgery and from autopsied control patients (n&#x202f;=&#x2009;14). Herein, the presence of PVB19, EBV, CMV, HHV&#x2011;6, adenovirus and enterovirus genomes was determined by polymerase chain reaction. The densities of CD45+ and CD3+ cells and fibrosis in the atria were quantified by (immuno)histochemistry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the tested viruses only the PVB19 genome was detected in the atria of 10% of patients, paroxysmal AF (2&#xa0;of 20)&#xa0;and long-standing persistent/permanent AF (3&#xa0;of 30). Conversely, in 50% of controls (7&#xa0;of 14) PVB19 genome was found. No significant association was found between PVB19 and CD45+ and CD3+ cells, or between the presence of PVB19 and fibrosis, in either control or AF patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The presence of viral genomes is not increased in the atria of AF patients. These results do not support an important role for viral infection of the atria in the pathogenesis of AF.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>L</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9419-9011</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centre, location VUmc and AMC, Amsterdam, The Netherlands. l.wu1@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands. l.wu1@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emmens</LastName><ForeName>R W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centre, location VUmc and AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Wezenbeek</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centre, location VUmc and AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stooker</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allaart</LastName><ForeName>C P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam University Medical Centre, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vonk</LastName><ForeName>A B A</ForeName><Initials>ABA</Initials><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Amsterdam University Medical Centre, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Rossum</LastName><ForeName>A C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam University Medical Centre, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolthers</LastName><ForeName>K C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Virology, Amsterdam University Medical Centre, location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niessen</LastName><ForeName>H W M</ForeName><Initials>HWM</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centre, location VUmc and AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Amsterdam University Medical Centre, location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krijnen</LastName><ForeName>P A J</ForeName><Initials>PAJ</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam University Medical Centre, location VUmc and AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>201708260020</GrantID><Agency>China Scholarship Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neth Heart J</MedlineTA><NlmUniqueID>101095458</NlmUniqueID><ISSNLinking>1568-5888</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Parvovirus B19</Keyword></KeywordList><CoiStatement>L.&#xa0;Wu, R.W.&#xa0;Emmens, J.&#xa0;van Wezenbeek, W.&#xa0;Stooker, C.P.&#xa0;Allaart, A.B.A.&#xa0;Vonk, A.C.&#xa0;van Rossum, K.C.&#xa0;Wolthers, H.W.M.&#xa0;Niessen and P.A.J.&#xa0;Krijnen declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>31</Day><Hour>12</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35099775</ArticleId><ArticleId IdType="pmc">PMC9270523</ArticleId><ArticleId IdType="doi">10.1007/s12471-022-01660-4</ArticleId><ArticleId IdType="pii">10.1007/s12471-022-01660-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893&#x2013;2962. doi: 10.1093/eurheartj/ehw210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw210</ArticleId><ArticleId IdType="pubmed">27567408</ArticleId></ArticleIdList></Reference><Reference><Citation>Begieneman MP, Emmens RW, Rijvers L, et al. Ventricular myocarditis coincides with atrial myocarditis in patients. Cardiovasc Pathol. 2016;25:141&#x2013;148. doi: 10.1016/j.carpath.2015.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2015.12.001</ArticleId><ArticleId IdType="pubmed">26764148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Emmens RW, van Wezenbeek J, et al. Atrial inflammation in different atrial fibrillation subtypes and its relation with clinical risk factors. Clin Res Cardiol. 2020;109:1271&#x2013;1281. doi: 10.1007/s00392-020-01619-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01619-8</ArticleId><ArticleId IdType="pmc">PMC7515944</ArticleId><ArticleId IdType="pubmed">32072262</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang TY, Chao TF, Liu CJ, et al. The association between influenza infection, vaccination, and atrial fibrillation: a&#xa0;nationwide case-control study. Heart Rhythm. 2016;13:1189&#x2013;1194. doi: 10.1016/j.hrthm.2016.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2016.01.026</ArticleId><ArticleId IdType="pubmed">26850784</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu JC, Li Y, Marcus GM, et al. Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity. J Am Coll Cardiol. 2013;61:2288&#x2013;2295. doi: 10.1016/j.jacc.2013.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.03.022</ArticleId><ArticleId IdType="pubmed">23563125</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha M-J, Seo H-M, Choi E-K, et al. Increased risk of atrial fibrillation in the early period after herpes zoster infection: a&#xa0;nationwide population-based case-control study. J Korean Med Sci. 2018;33:e160. doi: 10.3346/jkms.2018.33.e160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2018.33.e160</ArticleId><ArticleId IdType="pmc">PMC5966375</ArticleId><ArticleId IdType="pubmed">29805341</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang CH, Huang CC, Chan WL, et al. Herpes simplex virus infection and risk of atrial fibrillation: a&#xa0;nationwide study. Int J Cardiol. 2013;164:201&#x2013;204. doi: 10.1016/j.ijcard.2011.06.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.06.126</ArticleId><ArticleId IdType="pubmed">21782262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichiki H, Orihara K, Hamasaki S, et al. The role of infection in the development of non-valvular atrial fibrillation: up-regulation of Toll-like receptor 2 expression levels on monocytes. J Cardiol. 2009;53:127&#x2013;135. doi: 10.1016/j.jjcc.2008.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2008.09.008</ArticleId><ArticleId IdType="pubmed">19167648</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu DM, Zhou ZK, Fan SH, et al. Comprehensive RNA-Seq data analysis identifies key mRNAs and lncRNAs in atrial fibrillation. Front Genet. 2019;10:908. doi: 10.3389/fgene.2019.00908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00908</ArticleId><ArticleId IdType="pmc">PMC6783610</ArticleId><ArticleId IdType="pubmed">31632440</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar S, Liu PP, Cooper LT., Jr Myocarditis. Lancet. 2012;379:738&#x2013;747. doi: 10.1016/S0140-6736(11)60648-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60648-X</ArticleId><ArticleId IdType="pmc">PMC5814111</ArticleId><ArticleId IdType="pubmed">22185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto I, Hagiwara A. Studies on the pathogenesis of atrial myocarditis in mice infected with Coxsackie virus B3. Br J Exp Pathol. 1986;67:43&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2013065</ArticleId><ArticleId IdType="pubmed">3947534</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA. Viral myocarditis and dilated cardiomyopathy: etiology and pathogenesis. Curr Pharm Des. 2016;22:408&#x2013;426. doi: 10.2174/1381612822666151222160500.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612822666151222160500</ArticleId><ArticleId IdType="pubmed">26696257</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrichs K, Klinke A, Baldus S. Inflammatory pathways underlying atrial fibrillation. Trends Mol Med. 2011;17:556&#x2013;563. doi: 10.1016/j.molmed.2011.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2011.05.007</ArticleId><ArticleId IdType="pubmed">21763201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuethe F, Lindner J, Matschke K, et al. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis. 2009;49:1660&#x2013;1666. doi: 10.1086/648074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/648074</ArticleId><ArticleId IdType="pubmed">19863443</ArticleId></ArticleIdList></Reference><Reference><Citation>Traylen CM, Patel HR, Fondaw W, et al. Virus reactivation: a&#xa0;panoramic view in human infections. Future Virol. 2011;6:451&#x2013;463. doi: 10.2217/fvl.11.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl.11.21</ArticleId><ArticleId IdType="pmc">PMC3142679</ArticleId><ArticleId IdType="pubmed">21799704</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdonschot J, Hazebroek M, Merken J, et al. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail. 2016;18:1430&#x2013;1441. doi: 10.1002/ejhf.665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.665</ArticleId><ArticleId IdType="pubmed">27748022</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallbracht KB, Schwimmbeck PL, Kuhl U, et al. Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates. Circulation. 2005;111:1784&#x2013;1791. doi: 10.1161/01.CIR.0000160863.30496.9B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000160863.30496.9B</ArticleId><ArticleId IdType="pubmed">15809378</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenk T, Enders M, Pollak S, Hahn R, Huzly D. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol. 2009;47:106&#x2013;110. doi: 10.1128/JCM.01672-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01672-08</ArticleId><ArticleId IdType="pmc">PMC2620852</ArticleId><ArticleId IdType="pubmed">19005147</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;oletti L, Bourlet T, Moukassa D, et al. Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy. J Infect Dis. 2000;182:1222&#x2013;1227. doi: 10.1086/315818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315818</ArticleId><ArticleId IdType="pubmed">10979922</ArticleId></ArticleIdList></Reference><Reference><Citation>Abad C, Cardenes MA, Jimenez PC, Armas MV, Betancor P. Cardiac surgery in patients infected with human immunodeficiency virus. Tex Heart Inst J. 2000;27:356&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC101104</ArticleId><ArticleId IdType="pubmed">11198308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Roa P, Perez-Granda MJ, Munoz P, et al. A prospective monitoring study of cytomegalovirus infection in non-immunosuppressed critical heart surgery patients. PLoS ONE. 2015;10:e0129447. doi: 10.1371/journal.pone.0129447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0129447</ArticleId><ArticleId IdType="pmc">PMC4466502</ArticleId><ArticleId IdType="pubmed">26070136</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>